Stifel Nicolaus Has Lowered Expectations for Colgate-Palmolive (NYSE:CL) Stock Price

Colgate-Palmolive (NYSE:CL) had its target price lowered by equities research analysts at Stifel Nicolaus from $101.00 to $95.00 in a report issued on Friday,Benzinga reports. The firm currently has a “hold” rating on the stock. Stifel Nicolaus’ price target would suggest a potential upside of 6.99% from the stock’s current price.

Other analysts have also recently issued research reports about the company. UBS Group lowered their price objective on Colgate-Palmolive from $112.00 to $104.00 and set a “buy” rating for the company in a research report on Thursday. Barclays dropped their price target on Colgate-Palmolive from $96.00 to $83.00 and set an “equal weight” rating on the stock in a research note on Friday. TD Cowen decreased their price objective on shares of Colgate-Palmolive from $110.00 to $100.00 and set a “buy” rating for the company in a research report on Wednesday, January 8th. Wells Fargo & Company cut their price target on shares of Colgate-Palmolive from $92.00 to $83.00 and set an “underweight” rating on the stock in a research note on Tuesday, January 7th. Finally, Piper Sandler lowered their price objective on shares of Colgate-Palmolive from $121.00 to $112.00 and set an “overweight” rating for the company in a research note on Monday, January 6th. One analyst has rated the stock with a sell rating, ten have given a hold rating and twelve have issued a buy rating to the company’s stock. According to data from MarketBeat.com, Colgate-Palmolive presently has an average rating of “Hold” and an average target price of $101.11.

Colgate-Palmolive Trading Up 0.3 %

NYSE:CL opened at $88.79 on Friday. The stock has a market capitalization of $72.55 billion, a price-to-earnings ratio of 25.44, a PEG ratio of 3.01 and a beta of 0.44. Colgate-Palmolive has a 52 week low of $79.69 and a 52 week high of $109.30. The company has a quick ratio of 0.68, a current ratio of 1.04 and a debt-to-equity ratio of 9.46. The firm has a 50 day moving average of $92.20 and a 200 day moving average of $97.74.

Insiders Place Their Bets

In other news, CFO Stanley J. Sutula III sold 45,410 shares of the business’s stock in a transaction that occurred on Tuesday, November 5th. The stock was sold at an average price of $94.11, for a total value of $4,273,535.10. Following the completion of the sale, the chief financial officer now directly owns 36,726 shares in the company, valued at $3,456,283.86. The trade was a 55.29 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Insiders own 0.37% of the company’s stock.

Institutional Investors Weigh In On Colgate-Palmolive

Institutional investors have recently added to or reduced their stakes in the stock. Apeiron RIA LLC raised its position in Colgate-Palmolive by 5.1% during the fourth quarter. Apeiron RIA LLC now owns 7,745 shares of the company’s stock worth $704,000 after acquiring an additional 379 shares during the period. Whalen Wealth Management Inc. purchased a new position in Colgate-Palmolive in the 4th quarter valued at about $291,000. Wesbanco Bank Inc. lifted its stake in Colgate-Palmolive by 1.7% in the 4th quarter. Wesbanco Bank Inc. now owns 15,066 shares of the company’s stock valued at $1,370,000 after buying an additional 250 shares in the last quarter. Janney Montgomery Scott LLC boosted its holdings in Colgate-Palmolive by 2.2% in the 4th quarter. Janney Montgomery Scott LLC now owns 387,487 shares of the company’s stock worth $35,227,000 after buying an additional 8,293 shares during the last quarter. Finally, Atomi Financial Group Inc. increased its stake in Colgate-Palmolive by 6.5% during the 4th quarter. Atomi Financial Group Inc. now owns 6,489 shares of the company’s stock worth $590,000 after buying an additional 394 shares in the last quarter. Institutional investors and hedge funds own 80.41% of the company’s stock.

About Colgate-Palmolive

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.